Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models
Federica Maione, … , Federico Bussolino, Enrico Giraudo
Federica Maione, … , Federico Bussolino, Enrico Giraudo
Published October 5, 2009
Citation Information: J Clin Invest. 2009;119(11):3356-3372. https://doi.org/10.1172/JCI36308.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 4

Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models

  • Text
  • PDF
Abstract

Tumor growth and progression rely upon angiogenesis, which is regulated by pro- and antiangiogenic factors, including members of the semaphorin family. By analyzing 3 different mouse models of multistep carcinogenesis, we show here that during angiogenesis, semaphorin 3A (Sema3A) is expressed in ECs, where it serves as an endogenous inhibitor of angiogenesis that is present in premalignant lesions and lost during tumor progression. Pharmacologic inhibition of endogenous Sema3A during the angiogenic switch, the point when pretumoral lesions initiate an angiogenic phase that persists throughout tumor growth, enhanced angiogenesis and accelerated tumor progression. By contrast, when, during the later stages of carcinogenesis following endogenous Sema3A downmodulation, Sema3A was ectopically reintroduced into islet cell tumors by somatic gene transfer, successive waves of apoptosis ensued, first in ECs and then in tumor cells, resulting in reduced vascular density and branching and inhibition of tumor growth and substantially extended survival. Further, long-term reexpression of Sema3A markedly improved pericyte coverage of tumor blood vessels, something that is thought to be a key property of tumor vessel normalization, and restored tissue normoxia. We conclude, therefore, that Sema3A is an endogenous and effective antiangiogenic agent that stably normalizes the tumor vasculature.

Authors

Federica Maione, Fabiola Molla, Claudia Meda, Roberto Latini, Lorena Zentilin, Mauro Giacca, Giorgio Seano, Guido Serini, Federico Bussolino, Enrico Giraudo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 1 3 4 7 6 6 8 6 6 10 5 7 9 14 8 1 101
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (101)

Title and authors Publication Year
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Liu J, Zhang B, Huang B, Zhang K, Guo F, Wang Z, Shang D
Frontiers in Cell and Developmental Biology 2025
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism.
Yang F, Lee G, Fan Y
Angiogenesis 2024
The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes
Borlak J, Ciribilli Y, Bisio A, Selvaraj S, Inga A, Oh JH, Spanel R
Journal of Translational Medicine 2024
Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.
Lin L, Zou J, Pei S, Huang W, Zhang Y, Zhao Z, Ding Y, Xiao C
Heliyon 2024
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
D'Antonio L, Fieni C, Ciummo SL, Vespa S, Lotti L, Sorrentino C, Di Carlo E
Journal for ImmunoTherapy of Cancer 2023
Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity
Toledano S, Neufeld G
Cancers 2023
Alleviating hypoxia to improve cancer immunotherapy.
Fan P, Zhang N, Candi E, Agostini M, Piacentini M, Shi Y, Huang Y, Melino G
Oncogene 2023
Reduced expression of semaphorin 3A in osteoclasts causes lymphatic expansion in a Gorham-Stout disease (GSD) mouse model
Journal of Zhejiang University. Science. B 2023
Induction of PLXNA4 Gene during Neural Differentiation in Human Umbilical-Cord-Derived Mesenchymal Stem Cells by Low-Intensity Sub-Sonic Vibration.
Cho H, Park HJ, Seo YK
International journal of molecular sciences 2022
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
Ansari MJ, Bokov D, Markov A, Jalil AT, Shalaby MN, Suksatan W, Chupradit S, AL-Ghamdi HS, Shomali N, Zamani A, Mohammadi A, Dadashpour M
Cell communication and signaling : CCS 2022
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications.
Lauricella E, Mandriani B, Cavallo F, Pezzicoli G, Chaoul N, Porta C, Cives M
Frontiers in Oncology 2022
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.
Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M
Molecular Cancer 2022
The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments
Ieguchi K, Funakoshi M, Mishima T, Takizawa K, Omori T, Nakamura F, Watanabe M, Tsuji M, Kiuchi Y, Kobayashi S, Tsunoda T, Maru Y, Wada S
International journal of molecular sciences 2022
Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation
Liu T, Cheng S, Xu Q, Wang Z
Medicina 2022
Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis
Benwell CJ, Johnson RT, Taylor JA, Price CA, Robinson SD
2022
Neuropilin 1 Regulation of Vascular Permeability Signaling
A Domingues, A Fantin
Biomolecules 2021
Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment
VM Aspriţoiu, I Stoica, C Bleotu, CC Diaconu
Frontiers in Cell and Developmental Biology 2021
SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
E Valentini, MD Martile, DD Bufalo, S DAguanno
Journal of Experimental & Clinical Cancer Research 2021
The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
B Ferrara, C Pignatelli, M Cossutta, A Citro, J Courty, L Piemonti
Cancers 2021
Cerebrovascular development: mechanisms and experimental approaches
TJ Chico, EC Kugler
Cellular and Molecular Life Sciences 2021
Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model
M Kripnerová, HS Parmar, J Šána, A Kopková, L Radová, S Sopper, K Biernacki, J Jedlička, M Kohoutová, J Kuncová, J Peychl, E Rudolf, M Červinka, Z Houdek, P Dvořák, K Houfková, M Pešta, Z Tůma, M Dolejšová, F Tichánek, V Babuška, M Leba, O Slabý, J Hatina
Journal of Clinical Medicine 2021
CAR T-cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
Xiaodong Zhuang, Federica Maione, Joseph Robinson, Michael Bentley, Baksho Kaul, Katharine Whitworth, Neeraj Jumbu, Elizabeth Jinks, Jonas Bystrom, Pietro Gabriele, Elisabetta Garibaldi, Elena Delmastro, Zsuzsanna Nagy, David E Gilham, Enrico Giraudo, Roy Bicknell, Steven P. Lee
JCI Insight 2020
Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
V Iragavarapu-Charyulu, E Wojcikiewicz, A Urdaneta
Frontiers in immunology 2020
Pancreatic cancer stroma: an update on therapeutic targeting strategies
AN Hosein, RA Brekken, A Maitra
Nature Reviews Gastroenterology & Hepatology 2020
The Role of Semaphorins in Metabolic Disorders
Q Lu, L Zhu
International journal of molecular sciences 2020
Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study
X Zhang, S Shao, L Li
Cancers 2020
Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing
UA Okonkwo, L Chen, D Ma, VA Haywood, M Barakat, N Urao, LA DiPietro, R Kirchmair
PloS one 2020
Neuropilins in the Context of Tumor Vasculature
S Niland, JA Eble
International journal of molecular sciences 2019
Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression
S Toledano, I Nir-Zvi, R Engelman, O Kessler, G Neufeld
International journal of molecular sciences 2019
Alternative Strategies to Inhibit Tumor Vascularization
A Brossa, L Buono, S Fallo, AF Pla, L Munaron, B Bussolati
International journal of molecular sciences 2019
Premetastasis
Y Maru
Cold Spring Harbor Perspectives in Medicine 2019
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
JD Martin, G Seano, RK Jain
Annual Review of Physiology 2019
Transformation of the Transcriptomic Profile of Mouse Periocular Mesenchyme During Formation of the Embryonic Cornea
J Ma, P Lwigale
Investigative ophthalmology & visual science 2019
Multifaceted Functional Role of Semaphorins in Glioblastoma
C Angelucci, G Lama, G Sica
International journal of molecular sciences 2019
Skilled Movements in Mice Require Inhibition of Corticospinal Axon Collateral Formation in the Spinal Cord by Semaphorin Signaling
Z Gu, M Ueno, K Klinefelter, M Mamidi, T Yagi, Y Yoshida
The Journal of neuroscience : the official journal of the Society for Neuroscience 2019
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models
D Dettori, F Orso, E Penna, D Baruffaldi, S Brundu, F Maione, E Turco, E Giraudo, D Taverna
Molecular Therapy 2018
A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle
HS Yuan, S Katyal, JE Anderson
Oncotarget 2018
Guidance Molecules in Vascular Smooth Muscle
AC Finney, AW Orr
Frontiers in physiology 2018
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
M Świerczewska, A Klejewski, M Brązert, D Kaźmierczak, D Iżycki, M Nowicki, M Zabel, R Januchowski
Molecules (Basel, Switzerland) 2018
Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?
A Iyer, S Chapoval
International journal of molecular sciences 2018
Targeting Semaphorin 3C in Prostate Cancer with Small Molecules
CC Lee, RS Munuganti, JW Peacock, K Dalal, IZ Jiao, A Shepherd, L Liu, KJ Tam, CG Sedgwick, S Bhasin, KC Lee, L Gooding, B Vanderkruk, T Tombe, Y Gong, ME Gleave, A Cherkasov, CJ Ong
Journal of the Endocrine Society 2018
Methods in Molecular Biology
LT Alto, JR Terman
Methods in molecular biology (Clifton, N.J.) 2017
Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice
C Huang, Y Wang, JH Huang, W Liu
BMC Pharmacology and Toxicology 2017
Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors
M Chen, K Maeng, A Nawab, RA Francois, JK Bray, MK Reinhard, SL Boye, WW Hauswirth, FJ Kaye, G Aslanidi, A Srivastava, M Zajac-Kaye
Human Gene Therapy Methods 2017
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy
Z Diamantopoulou, ME Gilles, M Sader, M Cossutta, B Vallée, C Houppe, D Habert, B Brissault, E Leroy, F Maione, E Giraudo, D Destouches, J Penelle, J Courty, I Cascone
Oncotarget 2017
The role of semaphorins in immune responses and autoimmune rheumatic diseases
M Nishide, A Kumanogoh
Nature Reviews Rheumatology 2017
Making Connections: Guidance Cues and Receptors at Nonneural Cell–Cell Junctions
IV Beamish, L Hinck, TE Kennedy
Cold Spring Harbor perspectives in biology 2017
Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System
VJ Coulson-Thomas, YM Coulson-Thomas, TF Gesteira, WW Kao
The ocular surface 2016
The role of the semaphorins in cancer
G Neufeld, Y Mumblat, T Smolkin, S Toledano, I Nir-Zvi, K Ziv, O Kessler
Cell adhesion & migration 2016
VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans
M Kazemi, A Carrer, S Moimas, L Zandonà, R Bussani, B Casagranda, S Palmisano, P Prelazzi, M Giacca, L Zentilin, ND Manzini, M Giacca, S Zacchigna
Cancer Gene Therapy 2016
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling
D Avanzato, T Genova, AF Pla, M Bernardini, S Bianco, B Bussolati, D Mancardi, E Giraudo, F Maione, P Cassoni, I Castellano, L Munaron
Scientific Reports 2016
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity
V Leuci, F Maione, R Rotolo, E Giraudo, F Sassi, G Migliardi, M Todorovic, L Gammaitoni, G Mesiano, L Giraudo, P Luraghi, F Leone, F Bussolino, G Grignani, M Aglietta, L Trusolino, A Bertotti, D Sangiolo
Journal of Translational Medicine 2016
Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A
H Movassagh, N Tatari, L Shan, L Koussih, D Alsubait, M Khattabi, NS Redhu, M Roth, M Tamm, J Chakir, AS Gounni
Oncotarget 2016
Semaphorin Signaling
JR Terman
Semaphorin Signaling 2016
Chromatin association of XRCC5/6 in the absence of DNA damage depends on the XPE gene product DDB2
D Fantini, S Huang, JM Asara, S Bagchi, P Raychaudhuri, WP Tansey
Molecular biology of the cell 2016
Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
FD Maggio, P Arumugam, FR Delvecchio, S Batista, T Lechertier, K Hodivala-Dilke, HM Kocher
Pancreatology 2016
Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma
Wang Z, Chen J, Zhang W, Zheng Y, Wang Z, Liu L, Wu H, Ye J, Zhang W, Qi B, Wu Y, Song X
Oncotarget 2016
Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage
ST Hou, L Nilchi, X Li, S Gangaraju, SX Jiang, A Aylsworth, R Monette, J Slinn
Scientific Reports 2015
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
F Maione, S Oliaro-Bosso, C Meda, FD Nicolantonio, F Bussolino, G Balliano, F Viola, E Giraudo
Scientific Reports 2015
VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF- 1 paracrine axis
E Groppa, S Brkic, E Bovo, S Reginato, V Sacchi, ND Maggio, MG Muraro, D Calabrese, M Heberer, R Gianni-Barrera, A Banfi
EMBO Molecular Medicine 2015
Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma
L Treps, S Edmond, E Harford-Wright, EM Galan-Moya, A Schmitt, S Azzi, A Citerne, N Bidère, D Ricard, J Gavard
Oncogene 2015
Bad vessels beware! Semaphorins will sort you out!
G Serini, L Tamagnone
EMBO Molecular Medicine 2015
Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice
V Agrawal, S Maharjan, K Kim, NJ Kim, J Son, K Lee, HJ Choi, SS Rho, S Ahn, MH Won, SJ Ha, GY Koh, YM Kim, YG Suh, YG Kwon
Oncotarget 2014
Neuropilin Regulation of Angiogenesis, Arteriogenesis, and Vascular Permeability
A Plein, A Fantin, C Ruhrberg
Microcirculation 2014
A perspective on the role of class III semaphorin signaling in central nervous system trauma
V Mecollari, B Nieuwenhuis, J Verhaagen
Frontiers in cellular neuroscience 2014
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
RK Jain
Cancer Cell 2014
Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility
V Procaccia, H Nakayama, A Shimizu, M Klagsbrun
Biochemical and Biophysical Research Communications 2014
Semaphorins and plexins as therapeutic targets
T Worzfeld, S Offermanns
Nature Reviews Drug Discovery 2014
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
JC Walsh, A Lebedev, E Aten, K Madsen, L Marciano, HC Kolb
Antioxidants & Redox Signaling 2014
Recruitment and retention: factors that affect pericyte migration
KY Aguilera, RA Brekken
Cellular and Molecular Life Sciences 2013
Mouse models for studying angiogenesis and lymphangiogenesis in cancer
L Eklund, M Bry, K Alitalo
Molecular Oncology 2013
Emerging roles of Semaphorins in the regulation of epithelial and endothelial junctions
L Treps, AL Guelte, J Gavard
Tissue Barriers 2013
The role of semaphorins and their receptors in vascular development and cancer
C Gu, E Giraudo
Experimental Cell Research 2013
Neurovascular development and links to disease
C Ruhrberg, VL Bautch
Cellular and Molecular Life Sciences 2013
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
BA Baldo, NH Pham
Cancer and Metastasis Reviews 2013
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
M Cesca, F Bizzaro, M Zucchetti, R Giavazzi
Frontiers in Oncology 2013
Immunological functions of the neuropilins and plexins as receptors for semaphorins
A Kumanogoh, H Kikutani
Nature Reviews Immunology 2013
Endothelial RAF1/ERK activation regulates arterial morphogenesis
Y Deng, B Larrivée, ZW Zhuang, D Atri, F Moraes, C Prahst, A Eichmann, M Simons
Blood 2013
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by anti-angiogenic treatment in mice
Federica Maione, Stefania Capano, Donatella Regano, Lorena Zentilin, Mauro Giacca, Oriol Casanovas, Federico Bussolino, Guido Serini, Enrico Giraudo
Journal of Clinical Investigation 2012
Semaphorin 6A regulates angiogenesis by modulating VEGF signaling
M Segarra, H Ohnuki, D Maric, O Salvucci, X Hou, A Kumar, X Li, G Tosato
Blood 2012
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
A Casazza, B Kigel, F Maione, L Capparuccia, O Kessler, E Giraudo, M Mazzone, G Neufeld, L Tamagnone
EMBO Molecular Medicine 2012
Neuropilins: expression and roles in the epithelium
JR Wild, CA Staton, K Chapple, BM Corfe
International Journal of Experimental Pathology 2012
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
S Goel, AH Wong, RK Jain
Cold Spring Harbor Perspectives in Medicine 2012
Semaphorins in Angiogenesis and Tumor Progression
G Neufeld, AD Sabag, N Rabinovicz, O Kessler
Cold Spring Harbor Perspectives in Medicine 2012
Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models
F Peng, Z Xu, J Wang, Y Chen, Q Li, Y Zuo, J Chen, X Hu, Q Zhou, Y Wang, H Ma, Y Bao, M Chen
PloS one 2012
Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
G Chakraborty, S Kumar, R Mishra, TV Patil, GC Kundu
PloS one 2012
Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain
AD Sabag, J Bode, D Fink, B Kigel, W Kugler, G Neufeld
PloS one 2012
Interplay of neuropilin-1 and semaphorin 3A after partial hepatectomy in rats
L Fu, T Kitamura, K Iwabuchi, S Ichinose, M Yanagida, H Ogawa, S Watanabe, T Maruyama, M Suyama, K Takamori
World journal of gastroenterology : WJG 2012
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
MW Kieran, R Kalluri, YJ Cho
Cold Spring Harbor Perspectives in Medicine 2012
Semaphorin3A, Neuropilin-1, and PlexinA1 Are Required for Lymphatic Valve Formation
K Bouvrée, I Brunet, R del Toro, E Gordon, C Prahst, B Cristofaro, T Mathivet, Y Xu, J Soueid, V Fortuna, N Miura, MS Aigrot, CH Maden, C Ruhrberg, JL Thomas, A Eichmann
Circulation research 2012
Double protection for weakened bones
M Zaidi, J Iqbal
Nature 2012
Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
Wong HK, Shimizu A, Kirkpatrick ND, Garkavtsev I, Chan AW, di Tomaso E, Klagsbrun M, Jain RK
Neoplasia (New York, N.Y.) 2012
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain
Physiological reviews 2011
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
P Carmeliet, RK Jain
Nature Reviews Drug Discovery 2011
Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer
A Sakurai, C Doci, JS Gutkind
Cell Research 2011
Neuropilins: a new target for cancer therapy
C Grandclement, C Borg
Cancers 2011
In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9
V Jimenez, E Ayuso, C Mallol, J Agudo, A Casellas, M Obach, S Muñoz, A Salavert, F Bosch
Diabetologia 2011
αv Integrins in Angiogenesis and Cancer
SM Weis, DA Cheresh
Cold Spring Harbor Perspectives in Medicine 2011
Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A
JS Joyal, N Sitaras, F Binet, JC Rivera, A Stahl, K Zaniolo, Z Shao, A Polosa, T Zhu, D Hamel, M Djavari, D Kunik, JC Honoré, E Picard, A Zabeida, DR Varma, G Hickson, J Mancini, M Klagsbrun, S Costantino, C Beauséjour, P Lachapelle, LE Smith, S Chemtob, P Sapieha
Blood 2011
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis
A Gaziel-Sovran, MF Segura, RD Micco, MK Collins, D Hanniford, EV de Miera, JF Rakus, JF Dankert, S Shang, RS Kerbel, N Bhardwaj, Y Shao, F Darvishian, J Zavadil, A Erlebacher, LK Mahal, I Osman, E Hernando
Cancer Cell 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 1 Wikipedia pages
120 readers on Mendeley
See more details